| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.0063 | 1 |